Snapshot
The global Hereditary Angioedema Drug market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Hereditary Angioedema Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
By Product
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By Route of Administration
Oral
Intravenous
Subcutaneous Injection
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
The global Hereditary Angioedema Drug market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Hereditary Angioedema Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
By Product
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By Route of Administration
Oral
Intravenous
Subcutaneous Injection
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Hereditary Angioedema Drug Industry
Figure Hereditary Angioedema Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Hereditary Angioedema Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Hereditary Angioedema Drug
1.2.2 Downstream
Table Application Segment of Hereditary Angioedema Drug
Table Global Hereditary Angioedema Drug Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Hereditary Angioedema Drug Market by Type
3.1 By Type
3.1.1 By Product
Table Major Company List of By Product
3.1.2 C1 Esterase Inhibitor
Table Major Company List of C1 Esterase Inhibitor
3.1.3 Kallikrein Inhibitor
Table Major Company List of Kallikrein Inhibitor
3.1.4 Selective Bradykinin B2 Receptor Antagonist
Table Major Company List of Selective Bradykinin B2 Receptor Antagonist
3.1.5 By Route of Administration
Table Major Company List of By Route of Administration
3.1.6 Oral
Table Major Company List of Oral
3.1.7 Intravenous
Table Major Company List of Intravenous
3.1.8 Subcutaneous Injection
Table Major Company List of Subcutaneous Injection
3.2 Market Size
Table Global Hereditary Angioedema Drug Market 2015-2019, by Type, in USD Million
Figure Global Hereditary Angioedema Drug Market Growth 2015-2019, by Type, in USD Million
Table Global Hereditary Angioedema Drug Market 2015-2019, by Type, in Volume
Figure Global Hereditary Angioedema Drug Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Hereditary Angioedema Drug Market Forecast 2020-2025, by Type, in USD Million
Table Global Hereditary Angioedema Drug Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Pharming Group NV (Company Profile, Sales Data etc.)
4.1.1 Pharming Group NV Profile
Table Pharming Group NV Overview List
4.1.2 Pharming Group NV Products & Services
4.1.3 Pharming Group NV Business Operation Conditions
Table Business Operation of Pharming Group NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Shire plc (Company Profile, Sales Data etc.)
4.2.1 Shire plc Profile
Table Shire plc Overview List
4.2.2 Shire plc Products & Services
4.2.3 Shire plc Business Operation Conditions
Table Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 CSL Limited (Company Profile, Sales Data etc.)
4.3.1 CSL Limited Profile
Table CSL Limited Overview List
4.3.2 CSL Limited Products & Services
4.3.3 CSL Limited Business Operation Conditions
Table Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 iBio Inc. (Company Profile, Sales Data etc.)
4.4.1 iBio Inc. Profile
Table iBio Inc. Overview List
4.4.2 iBio Inc. Products & Services
4.4.3 iBio Inc. Business Operation Conditions
Table Business Operation of iBio Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 BioCryst Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.5.1 BioCryst Pharmaceuticals, Inc. Profile
Table BioCryst Pharmaceuticals, Inc. Overview List
4.5.2 BioCryst Pharmaceuticals, Inc. Products & Services
4.5.3 BioCryst Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of BioCryst Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Ionis Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.6.1 Ionis Pharmaceuticals, Inc. Profile
Table Ionis Pharmaceuticals, Inc. Overview List
4.6.2 Ionis Pharmaceuticals, Inc. Products & Services
4.6.3 Ionis Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Ionis Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Hereditary Angioedema Drug Sales Revenue 2015-2019, by Company, in USD Million
Table Global Hereditary Angioedema Drug Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Hereditary Angioedema Drug Sales Revenue Share in 2019, by Company, in USD Million
Table Global Hereditary Angioedema Drug Sales Volume 2015-2019, by Company, in Volume
Table Global Hereditary Angioedema Drug Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Hereditary Angioedema Drug Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Hereditary Angioedema Drug Market Concentration, in 2019
Figure Europe Hereditary Angioedema Drug Market Market Concentration, in 2019
Figure Asia-Pacific Hereditary Angioedema Drug MMarket Concentration, in 2019
Figure South America Hereditary Angioedema Drug Market Concentration, in 2019
Figure Middle East & Africa Hereditary Angioedema Drug Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Retail Pharmacies
Figure Hereditary Angioedema Drug Demand in Retail Pharmacies, 2015-2019, in USD Million
Figure Hereditary Angioedema Drug Demand in Retail Pharmacies, 2015-2019, in Volume
6.1.2 Demand in Hospital Pharmacies
Figure Hereditary Angioedema Drug Demand in Hospital Pharmacies, 2015-2019, in USD Million
Figure Hereditary Angioedema Drug Demand in Hospital Pharmacies, 2015-2019, in Volume
6.1.3 Demand in Online Pharmacies
Figure Hereditary Angioedema Drug Demand in Online Pharmacies, 2015-2019, in USD Million
Figure Hereditary Angioedema Drug Demand in Online Pharmacies, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Hereditary Angioedema Drug Demand Forecast 2020-2025, by Application, in USD Million
Figure Hereditary Angioedema Drug Market Growth 2020-2025, by Application, in USD Million
Figure Hereditary Angioedema Drug Market Share in 2025, by Application, in USD Million
Table Hereditary Angioedema Drug Demand Forecast 2020-2025, by Application, in Volume
Table Hereditary Angioedema Drug Market Growth 2020-2025, by Application, in Volume
Table Hereditary Angioedema Drug Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Hereditary Angioedema Drug Production 2015-2019, by Region, in USD Million
Table Hereditary Angioedema Drug Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Hereditary Angioedema Drug Market 2015-2019, by Region, in USD Million
Table Global Hereditary Angioedema Drug Market Share 2015-2019, by Region, in USD Million
Table Global Hereditary Angioedema Drug Market 2015-2019, by Region, in Volume
Table Global Hereditary Angioedema Drug Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Hereditary Angioedema Drug Market Size and Growth 2015-2019, in USD Million
Figure North America Hereditary Angioedema Drug Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Hereditary Angioedema Drug Market Size 2015-2019, by Country, in USD Million
Table North America Hereditary Angioedema Drug Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Hereditary Angioedema Drug Market Size and Growth 2015-2019, in USD Million
Figure Europe Hereditary Angioedema Drug Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Hereditary Angioedema Drug Market Size 2015-2019, by Country, in USD Million
Table Europe Hereditary Angioedema Drug Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Hereditary Angioedema Drug Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Hereditary Angioedema Drug Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Hereditary Angioedema Drug Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Hereditary Angioedema Drug Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Hereditary Angioedema Drug Market Size and Growth 2015-2019, in USD Million
Figure South America Hereditary Angioedema Drug Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Hereditary Angioedema Drug Market Size 2015-2019, by Country, in USD Million
Table South America Hereditary Angioedema Drug Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Hereditary Angioedema Drug Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Hereditary Angioedema Drug Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Hereditary Angioedema Drug Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Hereditary Angioedema Drug Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Hereditary Angioedema Drug Market Forecast 2020-2025, by Region, in USD Million
Table Hereditary Angioedema Drug Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
1 Industry Overview
1.1 Hereditary Angioedema Drug Industry
Figure Hereditary Angioedema Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Hereditary Angioedema Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Hereditary Angioedema Drug
1.2.2 Downstream
Table Application Segment of Hereditary Angioedema Drug
Table Global Hereditary Angioedema Drug Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Hereditary Angioedema Drug Market by Type
3.1 By Type
3.1.1 By Product
Table Major Company List of By Product
3.1.2 C1 Esterase Inhibitor
Table Major Company List of C1 Esterase Inhibitor
3.1.3 Kallikrein Inhibitor
Table Major Company List of Kallikrein Inhibitor
3.1.4 Selective Bradykinin B2 Receptor Antagonist
Table Major Company List of Selective Bradykinin B2 Receptor Antagonist
3.1.5 By Route of Administration
Table Major Company List of By Route of Administration
3.1.6 Oral
Table Major Company List of Oral
3.1.7 Intravenous
Table Major Company List of Intravenous
3.1.8 Subcutaneous Injection
Table Major Company List of Subcutaneous Injection
3.2 Market Size
Table Global Hereditary Angioedema Drug Market 2015-2019, by Type, in USD Million
Figure Global Hereditary Angioedema Drug Market Growth 2015-2019, by Type, in USD Million
Table Global Hereditary Angioedema Drug Market 2015-2019, by Type, in Volume
Figure Global Hereditary Angioedema Drug Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Hereditary Angioedema Drug Market Forecast 2020-2025, by Type, in USD Million
Table Global Hereditary Angioedema Drug Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Pharming Group NV (Company Profile, Sales Data etc.)
4.1.1 Pharming Group NV Profile
Table Pharming Group NV Overview List
4.1.2 Pharming Group NV Products & Services
4.1.3 Pharming Group NV Business Operation Conditions
Table Business Operation of Pharming Group NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Shire plc (Company Profile, Sales Data etc.)
4.2.1 Shire plc Profile
Table Shire plc Overview List
4.2.2 Shire plc Products & Services
4.2.3 Shire plc Business Operation Conditions
Table Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 CSL Limited (Company Profile, Sales Data etc.)
4.3.1 CSL Limited Profile
Table CSL Limited Overview List
4.3.2 CSL Limited Products & Services
4.3.3 CSL Limited Business Operation Conditions
Table Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 iBio Inc. (Company Profile, Sales Data etc.)
4.4.1 iBio Inc. Profile
Table iBio Inc. Overview List
4.4.2 iBio Inc. Products & Services
4.4.3 iBio Inc. Business Operation Conditions
Table Business Operation of iBio Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 BioCryst Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.5.1 BioCryst Pharmaceuticals, Inc. Profile
Table BioCryst Pharmaceuticals, Inc. Overview List
4.5.2 BioCryst Pharmaceuticals, Inc. Products & Services
4.5.3 BioCryst Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of BioCryst Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Ionis Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.6.1 Ionis Pharmaceuticals, Inc. Profile
Table Ionis Pharmaceuticals, Inc. Overview List
4.6.2 Ionis Pharmaceuticals, Inc. Products & Services
4.6.3 Ionis Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Ionis Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Hereditary Angioedema Drug Sales Revenue 2015-2019, by Company, in USD Million
Table Global Hereditary Angioedema Drug Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Hereditary Angioedema Drug Sales Revenue Share in 2019, by Company, in USD Million
Table Global Hereditary Angioedema Drug Sales Volume 2015-2019, by Company, in Volume
Table Global Hereditary Angioedema Drug Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Hereditary Angioedema Drug Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Hereditary Angioedema Drug Market Concentration, in 2019
Figure Europe Hereditary Angioedema Drug Market Market Concentration, in 2019
Figure Asia-Pacific Hereditary Angioedema Drug MMarket Concentration, in 2019
Figure South America Hereditary Angioedema Drug Market Concentration, in 2019
Figure Middle East & Africa Hereditary Angioedema Drug Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Retail Pharmacies
Figure Hereditary Angioedema Drug Demand in Retail Pharmacies, 2015-2019, in USD Million
Figure Hereditary Angioedema Drug Demand in Retail Pharmacies, 2015-2019, in Volume
6.1.2 Demand in Hospital Pharmacies
Figure Hereditary Angioedema Drug Demand in Hospital Pharmacies, 2015-2019, in USD Million
Figure Hereditary Angioedema Drug Demand in Hospital Pharmacies, 2015-2019, in Volume
6.1.3 Demand in Online Pharmacies
Figure Hereditary Angioedema Drug Demand in Online Pharmacies, 2015-2019, in USD Million
Figure Hereditary Angioedema Drug Demand in Online Pharmacies, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Hereditary Angioedema Drug Demand Forecast 2020-2025, by Application, in USD Million
Figure Hereditary Angioedema Drug Market Growth 2020-2025, by Application, in USD Million
Figure Hereditary Angioedema Drug Market Share in 2025, by Application, in USD Million
Table Hereditary Angioedema Drug Demand Forecast 2020-2025, by Application, in Volume
Table Hereditary Angioedema Drug Market Growth 2020-2025, by Application, in Volume
Table Hereditary Angioedema Drug Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Hereditary Angioedema Drug Production 2015-2019, by Region, in USD Million
Table Hereditary Angioedema Drug Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Hereditary Angioedema Drug Market 2015-2019, by Region, in USD Million
Table Global Hereditary Angioedema Drug Market Share 2015-2019, by Region, in USD Million
Table Global Hereditary Angioedema Drug Market 2015-2019, by Region, in Volume
Table Global Hereditary Angioedema Drug Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Hereditary Angioedema Drug Market Size and Growth 2015-2019, in USD Million
Figure North America Hereditary Angioedema Drug Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Hereditary Angioedema Drug Market Size 2015-2019, by Country, in USD Million
Table North America Hereditary Angioedema Drug Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Hereditary Angioedema Drug Market Size and Growth 2015-2019, in USD Million
Figure Europe Hereditary Angioedema Drug Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Hereditary Angioedema Drug Market Size 2015-2019, by Country, in USD Million
Table Europe Hereditary Angioedema Drug Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Hereditary Angioedema Drug Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Hereditary Angioedema Drug Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Hereditary Angioedema Drug Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Hereditary Angioedema Drug Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Hereditary Angioedema Drug Market Size and Growth 2015-2019, in USD Million
Figure South America Hereditary Angioedema Drug Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Hereditary Angioedema Drug Market Size 2015-2019, by Country, in USD Million
Table South America Hereditary Angioedema Drug Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Hereditary Angioedema Drug Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Hereditary Angioedema Drug Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Hereditary Angioedema Drug Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Hereditary Angioedema Drug Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Hereditary Angioedema Drug Market Forecast 2020-2025, by Region, in USD Million
Table Hereditary Angioedema Drug Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
